[1] Chrysant, S. G., & Chrysant, G. S. (2019). Association of hypomagnesemia with cardiovascular diseases and hypertension. International Journal of Cardiology. Hypertension, 1, 100005. https://doi.org/10.1016/j.ijchy.2019.100005

[2] Efstratiadis, G., Sarigianni, M., & Gougourelas, I. (2006). Hypomagnesemia and cardiovascular system. Hippokratia, 10(4), 147–152.

[3] Kieboom, B. C., Niemeijer, M. N., Leening, M. J., van den Berg, M. E., Franco, O. H., Deckers, J. W., Hofman, A., Zietse, R., Stricker, B. H., & Hoorn, E. J. (2016). Serum magnesium and the risk of death from coronary heart disease and sudden cardiac death. Journal of the American Heart Association, 5, e002707. https://doi.org/10.1161/JAHA.115.002707

[4] Humphries, E. S., & Dart, C. (2015). Neuronal and cardiovascular potassium channels as therapeutic drug targets: Promise and pitfalls. Journal of Biomolecular Screening, 20, 1055–1073. https://doi.org/10.1177/1087057115601677

[5] Patil, V. N., Ilanchezhian, T., & Aarti, Y. M. (2022). Role of electrolytes in cardiovascular disease (CVD) among Dhule population. Galore International Journal of Health Sciences and Research, 7, 46–50. https://doi.org/10.52403/gijhsr.20220107

[6] Hasan, M. Z., Nahar, K., Sharif, J. U., Paul, S. C., Thakur, A. K., Mahmud, A., Siddique, N. A., Islam, M. R., & Paul, G. K. (2023). Serum magnesium level and it’s relation in predicting adverse in-hospital outcome in patients with first attack of myocardial infarction. Mymensingh Medical Journal, 32, 65–72.

[7] Al Alawi, A. M., Majoni, S. W., & Falhammar, H. (2018). Magnesium and human health: Perspectives and research directions. International Journal of Endocrinology, 2018, 9041694. https://doi.org/10.1155/2018/9041694

[8] Sabah, Z., Wani, J., Deajim, M., Al Zomia, A. S., Asiri, A., Alqahtani, A. A., Alansari, W., Alwan, A., Al Qahtani, R. M., & Raj, B. (2023). Serum magnesium in patients with acute myocardial infarction and its effect on cardiac complications and mortality in myocardial infarction patients. Cureus, 15(4), e38147. https://doi.org/10.7759/cureus.38147

[9] Ahmed, F., & Mohammed, A. (2019). Magnesium: The Forgotten Electrolyte-A review on hypomagnesemia. Medical Sciences, 7(4), 56. https://doi.org/10.3390/medsci7040056

[10] Lal, L., & Murmu, H. (2016). Serum magnesium in patients with acute myocardial infarction. International Journal of Scientific Study, 4, 167–169.

[11] An, G., Du, Z., Meng, X., Guo, T., Shang, R., Li, J., An, F., Li, W., & Zhang, C. (2014). Association between low serum magnesium level and major adverse cardiac events in patients treated with drug-eluting stents for acute myocardial infarction. PLoS One, 9(6), e98971. https://doi.org/10.1371/journal.pone.0098971

[12] Vedamanickam, R., Anandan, P., & Bupesh, G. (2020). Evaluation of hypomagnesemia in acute myocardial infarction patients. Journal of Clinical and Diagnostic Research: JCDR, 14(1). https://doi.org/10.7860/JCDR/2020/42568.13455

[13] Nasim, B., Sajjad, A., Khan, Z., Ali, Z., Sheikh, A., Yadgir, T., Khan, W., Sakaf, O., & Naroo, G. (2016). Prevalence of ACS and causal relation of hypomagnesaemia. British Journal of Medicine and Medical Research, 12, 1–5. https://doi.org/10.9734/BJMMR/2016/19850

[14] Taha, A., & Mirghani, H. (2017). Basic clinical characteristics and hospital outcomes of acute coronary syndrome Patients-Sudan. Sudan Journal of Medical Sciences, 12, 52–62.

[15] Youssef, G., Saad, Z., Ammar, W., & Sharaf, Y. (2018). Assessment of left ventricular regional wall motion abnormalities using regional time-volume curves obtained by real time three-dimensional echocardiography. The Egyptian Heart Journal, 70(3), 189–194. https://doi.org/10.1016/j.ehj.2018.02.002

[16] Mutar, M., Merza, M. A., Issa, H. A., & Shaikhow, S. K. (2016). Risk factors and angiographic findings in patients with LBBB who underwent coronary angiography in Duhok Heart Center. Journal of Medical Science and clinical Research, 4(11), 14112– 14117. https://doi.org/10.18535/jmscr/v4i11.96

[17] Ghaffari, S., Rajabi, N., Alizadeh, A., & Azarfarin, R. (2008). Predictors of ventricular dysfunction and coronary artery disease in Iranian patients with left bundle branch block. International Journal of Cardiology, 130, 291–293. https://doi.org/10.1016/j.ijcard.2007.05.117

[18] Kolte, D., Vijayaraghavan, K., Khera, S., Sica, D. A., & Frishman, W. H. (2014). Role of magnesium in cardiovascular diseases. Cardiology, 22, 182–192. https://doi.org/10.1097/CRD.0000000000000003

[19] Singh, H., Khosla, P., & Kaur, J. (2023). A study of serum magnesium levels in acute myocardial infarction and its association with clinical outcome. National Journal of Physiology, Pharmacy and Pharmacology, 13(02), 286–291.

[20] Vassalle, C., Battaglia, D., Vannucci, A., Chatzianagnostou, K., Landi, P., Arvia, C., & Carpeggiani, C. (2016). Low magnesium is not a significant predictor of hard events in acute myocardial infarction. BBA Clinical, 5, 130–133. https://doi.org/10.1016/j.bbacli.2016.03.003

[21] Taneva, E. (2005). Hypokaliaemia and hypomagnesemia during acute coronary syndrome: A- 661. European Journal of Anaesthesiology, 22(34), 172. https://doi.org/10.1097/00003643-200505001- 00621